Skip to main content

Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human, Mouse, Goat

Applications

Validated:

Western Blot

Cited:

Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Western Blot, Flow Cytometry, Immunocytochemistry

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant human SIGIRR
Met1-His118
Accession # Q6IA17

Specificity

Detects human SIGIRR in direct ELISAs and Western blots. In direct ELISAs, less than 2% cross-reactivity with recombinant human (rh) IL‑1 R9, rhIL-1 R1, rhIL-1 R2, rhIL-1 R3, rhIL-1 R6, rhIL-1 R7, rhIL-1 R8, and rhIL-18 R is observed.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Scientific Data Images for Human SIGIRR Antibody

Detection of SIGIRR by Western Blot

Detection of SIGIRR by Western Blot

The expression of the cell surface of the SIGIRR is downregulated in CF cells. (A,B) Cell surface expression of the SIGIRR in (A) C38 and IB3-1, (B) NHBE and DHBE-CF (non-CF vs. CF) airway epithelial cells were assessed by biotinylation assay, followed by immunoblotting using anti-SIGIRR, calreticulin (CRT) and Sp1 antibodies. Protein bands in (A) were scanned, and relative band intensities were normalized to the beta-actin band. The graphs represent the average relative band intensity with S.D. from four independent experiments. * p < 0.05; Student’s t-test (n = 3). (C) Flow cytometry for the SIGIRR was performed using C38 and IB3-1 cells. Surface expressions of the SIGIRR were indicated by a fluorescence shift compared to the isotype control antibody (dotted line). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35887095), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of SIGIRR by Western Blot

Detection of SIGIRR by Western Blot

The expression of the cell surface of the SIGIRR is downregulated in CF cells. (A,B) Cell surface expression of the SIGIRR in (A) C38 and IB3-1, (B) NHBE and DHBE-CF (non-CF vs. CF) airway epithelial cells were assessed by biotinylation assay, followed by immunoblotting using anti-SIGIRR, calreticulin (CRT) and Sp1 antibodies. Protein bands in (A) were scanned, and relative band intensities were normalized to the beta-actin band. The graphs represent the average relative band intensity with S.D. from four independent experiments. * p < 0.05; Student’s t-test (n = 3). (C) Flow cytometry for the SIGIRR was performed using C38 and IB3-1 cells. Surface expressions of the SIGIRR were indicated by a fluorescence shift compared to the isotype control antibody (dotted line). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35887095), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of SIGIRR by Western Blot

Detection of SIGIRR by Western Blot

Suppression of IL-8 production by IL-37b is dependent on the cell surface-expressed WT-SIGIRR, leading to the attenuation of JNK phosphorylation. (A,B) C38 and IB3-1 cells were stimulated with 1 μg/mL flagellin or 20 μg/mL poly(I:C) 2 h after treatment with the indicated concentrations of a precursor or Val46 IL-37b. After 24 h, released IL-8 in the condition media was measured by ELISA. (C) NHBE and DHBE-CF cells were stimulated with 0.5 μg/mL poly(I:C) 2 h after treatment with 10 ng/mL of a precursor or Val46 IL-37b. After 24 h, released IL-8 in the condition media was measured by ELISA. (D) C38 and IB3-1 cells and (E) NHBE and DHBE-CF cells were stimulated with poly(I:C) (D, 20 μg/mL; E, 1 μg/mL) 2 h after treatment with a 10 ng/mL precursor of IL-37b. After the indicated period of the poly(I:C) treatment, the total cell lysates were subjected to immunoblotting using antibodies against the phospho-active form of MAPKs, IRF3, and I kappaB alpha. (F,G) pcDNA or delta8-SIGIRR-transfected C38 cells and (H and I) pcDNA or the WT-SIGIRR-transfected IB3-1 cells were stimulated with 20 μg/mL poly(I:C) 2 h after treatment with the indicated concentrations of the precursor of IL-37b. After 24 h, released IL-8 in the condition media was measured by ELISA. Exogenously expressed delta8 and the WT-SIGIRR were assessed by immunoblotting with the anti-SIGIRR. For the immunoblotting experiments (D–F,H), beta-actin was used as a loading control. (A–C,G,I) Results represent the mean ± S.D. * p < 0.05, ** p < 0.01, *** p < 0.001 versus poly(I:C)-treated cells; ANOVA with Dunnett’s test (n = 3). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35887095), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human SIGIRR Antibody

Application
Recommended Usage

Western Blot

0.1 µg/mL
Sample: Recombinant Human SIGIRR Fc Chimera (Catalog # 990-SG)

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: SIGIRR

The Interleukin 1 receptor family (IL-1 R) comprises at least eleven members including IL-1 RI (IL-1 R1), IL-1 RII (IL-1 R2), IL-1 RAcP (IL‑1 R3), ST2 (T1/IL-1 R4), IL-18 Ra (IL-1 Rrp/IL-1 R5), IL-1 Rrp2 (IL-1 RL2/IL-1 R6), IL-18 Rb (AcPL/IL-1 R7), IL-1RAPL‑1 (TIGIRR‑2/IL1RAPL1), and TIGIRR-1 (IL-1 R9) (1). All family members possess three immunoglobulin (Ig)-like domains in their extracellular region. Most members have an intracellular TIR (Toll-like receptor/IL-1 receptor signaling) domain that is also conserved in the Toll-like receptor family. Five of the IL-1 R family members (1, 2, 4, 5, and 6) are clustered and localized to chromosome 2. SIGIRR (single Ig domain containing IL-1 receptor-related molecule) is a subtype of the IL-1 R family that differs from the other nine members by having only one Ig domain in its extracellular region. The sequence of human SIGIRR predicts a 410 amino acid (aa) residue transmembrane glycoprotein that lacks signal peptide and contains a 118 aa single Ig extracellular domain, a transmembrane region and a 268 aa cytoplasmic tail with a TIR domain. The cytoplasmic tail of SIGIRR contains a C-terminal extention beyond the TIR domain which is also found in IL1RAPL1, IL-1 R9, and Toll-like receptor family members but absent in other IL-1 receptor family members. SIGIRR is widely expressed and is present in all cells and tissues examined. Mouse and human SIGIRR share 82% amino acid sequence identity. The ligand and signaling mechanism for SIGIRR has not been identified.

References

  1. Thomassen, E. et al. (1999) Cytokine 11:389.

Long Name

Single lg IL-1 Related Protein

Alternate Names

IL-1R8, TIR8

Entrez Gene IDs

59307 (Human); 24058 (Mouse)

Gene Symbol

SIGIRR

UniProt

Additional SIGIRR Products

Product Documents for Human SIGIRR Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human SIGIRR Antibody

For research use only

Loading...
Loading...
Loading...
Loading...